Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYellow Cake Regulatory News (YCA)

Share Price Information for Yellow Cake (YCA)

Share Price is delayed by 15 minutes
Get Live Data
560.50    -12.50 (-2.18%)
Bid:
560.00
Ask:
561.50
Spread: 1.50 (0.268%)
Market Cap: £1.42b
YCA Live PriceLast checked at - London Stock Exchange

Intraday Yellow Cake Share Chart

Share Buyback Programme

30 Apr 2020 07:00

RNS Number : 3990L
Yellow Cake PLC
30 April 2020
 

30 April 2020

 

 

 Yellow Cake plc ("Yellow Cake" or the "Company")

Share Buyback Programme

 

Yellow Cake, a specialist company operating in the uranium sector with a view to holding physical uranium for the long term, is pleased to announce a three month extension of its share buyback programme, which commenced on 22 January 2020, to purchase up to US$2 million of the Company's Ordinary Shares (the Programme"). 

At the Programme's inception, the Company's shares were trading at a material discount to its underlying net asset value. The Yellow Cake Board therefore took the decision to implement a share buyback programme as a means of effectively acquiring exposure to uranium at a discount to the commodity spot price and delivering value to its shareholders.

As at 29 April 2020, the Company had purchased 413,067 shares (held in treasury) at a volume weighted average price of £1.87 per share and at a volume-weighted average discount to NAV of 16%. The Company has incurred US$985,868 on the purchase of its shares to date (inclusive of those purchases made to date). 

Given that the Company's shares continue to trade at a significant discount to net asset value, the Yellow Cake Board has decided to extend the Programme to the earlier of 21 July 2020 or the date on which US$2 million has been incurred in the purchase of the Company's shares.

Purchases pursuant to the Programme will be made under the authority the Company has in place to make market acquisitions in accordance with the Jersey Companies Law (the "Existing Authority"). The Existing Authority permits the purchase of a maximum of 8,821,572 Ordinary Shares at a maximum price (excluding expenses) of 105 per cent. of the average market value of an Ordinary Share as derived from the AIM Appendix to the London Stock Exchange Daily Official List for the five business days immediately preceding the date of purchase. The Programme will be conducted in compliance with the Market Abuse Regulation (EU) No. 596/2014 and Commission Delegated Regulation (EU) No. 2016/1052. The Company intends to hold those Ordinary Shares purchased under the Programme in treasury.

Purchases will be carried out in compliance with the relevant conditions for trading, restrictions regarding time and volume, disclosure and reporting obligations, and price conditions. The Ordinary Shares will be repurchased at a price (excluding expenses) that does not exceed the last independent trade or the highest current independent bid on the relevant trading platform.

Yellow Cake has entered into an agreement with the Company's Joint Broker, Numis Securities Limited ("Numis"), to carry out on-market purchases of its Ordinary Shares. The agreement grants Numis the authority to enact purchases and make trading decisions concerning the timing of the purchases under the Programme independently of the Company.

Details of any purchases made under the Programme will be provided via RNS announcements and published on the Company's website.

Andre Liebenberg, CEO of Yellow Cake said: "By extending the successful buyback programme, we are able to take advantage of current market dynamics to acquire further uranium exposure at a discount to the spot price. The discount to NAV widened at the start of the coronavirus pandemic but has since been narrowing. Given the expected tightening of supply, the rising uranium price and our asset value, we would expect this to continue. A combination of further coronavirus-related supply side pressures, together with the long awaited publication of the US Nuclear Fuel Working Group's report, which brought to an end a long period of uncertainty for the uranium market, means we continue to believe the longer-term supply and demand characteristics of uranium make it a compelling investment opportunity."

 

 

ENQUIRIES:

 

Yellow Cake plc

 

 

Andre Liebenberg, CEO

Carole Whittall, CFO

 

Tel: +44 (0) 153 488 5200

 

 

 

 

 

Nominated Adviser and Joint Broker: Numis Securities Limited

 

John Prior

Paul Gillam

 

Alamgir Ahmed

 

 

Tel: +44 (0) 207 260 1000

 

 

 

 

 

Joint Broker: Berenberg

 

Matthew Armitt

Jennifer Wyllie

 

Detlir Elezi

 

 

Tel: +44 (0) 203 207 7800

 

 

 

 

 

Financial Adviser: Bacchus Capital Advisers

 

Peter Bacchus

Richard Allan

Tel: +44 (0) 203 848 1640

 

 

 

 

Investor Relations: Powerscourt

 

 

Peter Ogden

Linda Gu

 

Tel: +44 (0) 7793 858 211

 

 

 

 

 

 

 

 

 

 

ABOUT YELLOW CAKE

Yellow Cake is a London-listed company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through the acquisition of uranium royalties and streams or other uranium related activities. Yellow Cake seeks to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium related activities in a rising uranium price environment. The business is differentiated from its peers by its lower cost base and ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. Yellow Cake currently holds 9.62 million lb of U3O8, all of which is held in storage in North America. 

 

FORWARD LOOKING STATEMENTS

Certain statements contained herein are forward looking statements and are based on current expectations, estimates and projections about the potential returns of the Company and the industry and markets in which the Company will operate, the Directors' beliefs and assumptions made by the Directors. Words such as "expects", "anticipates", "should", "intends", "plans", "believes", "seeks", "estimates", "projects", "pipeline", "aims", "may", "targets", "would", "could" and variations of such words and similar expressions are intended to identify such forward looking statements and expectations. These statements are not guarantees of future performance or the ability to identify and consummate investments and involve certain risks, uncertainties and assumptions that are difficult to predict, qualify or quantify. Therefore, actual outcomes and results may differ materially from what is expressed in such forward looking statements or expectations. Among the factors that could cause actual results to differ materially are: uranium price volatility, difficulty in sourcing opportunities to buy or sell U3O8, foreign exchange rates, changes in political and economic conditions, competition from other energy sources, nuclear accident, loss of key personnel or termination of the services agreement with 308 Services Limited, changes in the legal or regulatory environment, insolvency of counterparties to the Company's material contracts or breach of such material contracts by such counterparties. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law or the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPPUMWCUPUGBB
Date   Source Headline
7th Dec 20227:00 amRNSInterim Report
9th Nov 20229:29 amRNSChanges to the Board of Directors
4th Nov 20227:00 amRNSAward of Share Options
31st Oct 20227:00 amRNSQuarterly Operating Update
7th Sep 202211:27 amRNSResults of 2022 Annual General Meeting
29th Jul 20227:00 amRNSNotice of AGM & Publication of 2022 Annual Report
28th Jul 20227:00 amRNSQUARTERLY OPERATING UPDATE
22nd Jul 20227:00 amRNSAnnual Results for the year ended 31 March 2022
15th Jul 20229:00 amRNSTR1: Notification of Major Holdings
1st Jul 20227:00 amRNSDELIVERY OF 950,000 LB OF U3O8
22nd Jun 20227:00 amRNSCOMMENCEMENT OF TRADING ON OTCQX
20th May 20227:00 amRNSDELIVERY OF URANIUM
10th May 20227:00 amRNSTR-1: Notification of major holdings
9th May 20227:00 amRNSCompletion of Buyback Programme
6th May 20223:10 pmRNSTransaction in Own Shares
6th May 20227:00 amRNSTransaction in Own Shares
5th May 20227:00 amRNSTransaction in Own Shares
4th May 202211:53 amRNSShare Buyback Programme extension
4th May 20227:00 amRNSTransaction in Own Shares
29th Apr 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSQUARTERLY OPERATING UPDATE
26th Apr 20226:22 pmRNSNOTIFICATION OF MAJOR HOLDINGS
25th Apr 20227:00 amRNSTransaction in Own Shares
22nd Apr 20227:00 amRNSTransaction in Own Shares
21st Apr 20227:00 amRNSTransaction in Own Shares
4th Apr 20227:00 amRNSUS$3 million Share Buyback Programme
4th Mar 20227:00 amRNSUpdate regarding 2021 Director Re-election
31st Jan 20227:00 amRNSQuarterly Operating Update
27th Jan 202211:40 amRNSResults of 2022 General Meeting
11th Jan 20227:00 amRNSNotice of General Meeting
9th Dec 20217:00 amRNSInterim Financial Report
22nd Nov 20217:00 amRNSExercise of Repurchase Option and Buyback Option
15th Nov 20215:16 pmRNSTR-1: Notification of major holdings
8th Nov 20217:00 amRNSQUARTERLY OPERATING UPDATE
3rd Nov 20217:00 amRNSTR-1: Notification of major holdings
3rd Nov 20217:00 amRNSTR-1: Notification of major holdings
29th Oct 20217:00 amRNSPurchase of 2mlb U3O8 at US$46.32/lb
27th Oct 20217:21 amRNSResults of Placing
26th Oct 20216:14 pmRNSProposed Uranium Purchase and Placing
30th Sep 20217:00 amRNSTR-1: Notification of major holdings
16th Sep 20213:08 pmRNSTR-1: Notification of major holdings – Replacement
10th Sep 202110:33 amRNSTR-1: Notification of Major Holdings
8th Sep 202111:00 amRNSResults of AGM
27th Aug 20217:00 amRNSPurchase of 2 million lb U3O8 for US$32.23/lb
2nd Aug 20217:00 amRNSQUARTERLY OPERATING UPDATE
26th Jul 20217:01 amRNSGrant and Exercise of Share Options
26th Jul 20217:00 amRNSPublication of Annual Report and AGM Notice
19th Jul 20217:00 amRNSAnnual Results for the year ended 31 March 2021
24th Jun 202112:45 pmRNSTR-1: Notification of major holdings - Replacement
24th Jun 20217:00 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.